François Moisson cofounded Excelya in 2014 with Frédéric Paqueville and, together, they drive the Executive Committee. Imbued with the entrepreneurial spirit, François began his career in consulting to better understand every aspect of successfully running a company. There, he worked with Frédéric, who shared his vision of creating a company in which all team members would actively participate in its development. The health sector naturally called through its ability to touch the lives of so many. After a few years in business development, he left to create Excelya which is now 900-strong across Europe.
Today, he defines Group strategy with Frédéric and ensures that Excelya’s original DNA – to care for its team members, clients and patients while delivering on its promise of excellence – is carried in each of its actions. He has a Master of Business Administration from IAE Paris La Sorbonne and an Engineering degree from Arts et Métiers Paristech.
Frédéric Paqueville cofounded Excelya in 2014. He now leads the group with François Moisson. Together, they are in charge of defining company strategy and the selection of new markets, offers and potential acquisitions. Before creating Excelya, Frédéric worked as Business Manager for a consulting firm. He left to create a company that would align with his desire to take good care of people while delivering outstanding business results. This was the genesis of Excelya. With François, they set out to produce a virtuous circle of people taken care of at work, their increased productivity and strengthened business. Since then, they have led Excelya from 2 to 800 employees, taking the company from a start-up to a European leader.
He has a Master of Business Administration from IAE Paris La Sorbonne and an Engineering Degree from Arts et Métiers Paristech.
Alan Morgan joined as Chief Executive Officer of Excelya in 2020 and is based in Paris. He defines company strategy with our cofounders and steers the Executive Committee. He has held numerous leadership positions in contract research organizations across Europe for the last 30 years. Prior to his current role, he served as Chief Operating Officer at Quanticate in the United Kingdom and, most notably, as Global Group President of ICON Clinical Research Services. He has also held executive positions at Covance, MDS Inc. (now part of Syneos) and RPS (now PRA).
He has led over 6000 people in 72 countries, repeatedly taking companies from small-scale to pan-European enterprises. He holds a Bachelor of Science from City University London and is a Fellow of the Chartered Certified Accountants.
Vivy ensures compliance, oversees quality management, supervises training and manages company-wide policies, procedures and insfrastructure. She has over 30 years of experience in Quality and Compliance in the health sector, including 15 with our Central European office. She has acted as Quality Assurance Director since 2015.
Vivy has more than 30 years of experience in drug development working for both CROs and pharmaceutical companies. Before that, Vivy worked for the major Greek players in the health industry, such as Gerolymatos International or ELPEN Pharmaceutical. She has significant experience in the creation, management and continuous improvement of quality management.
She holds a Bachelor Degree in Chemistry and in Economics and a Ph.D in Analytical Chemistry, obtained at the University of Athens.
Nathalie Doize has more than 30 years of experience in drug development working for both CROs and pharmaceutical companies. She oversees our operations and project delivery across Europe, ensuring excellence and the highest quality for our clients.
Nathalie joined Excelya from Syneos Health, where she served as Vice President of Operations and was responsible for the operation and oversight of operational teams in Europe and Asia Pacific. Before that, she served in a variety of roles in increasing seniority, including department management for Mapi Group, inVentiv Health Clinical and i3 Research. She has a nursing and pediatric nursing degree from Paris Nanterre University.
Emmanuelle was named Chief People Officer at Excelya in 2021. She has over 20 years’ experience in international HR leadership roles. In her prior company, Tech40 procurement leader Ivalua, Emmanuelle accompanied the acceleration, transformation and growth of the company by attracting the best talents and nurturing team development across the EMEA region. She has deep experience in creating a strong culture of engagement, agility and customer focus through initiatives encompassing smooth change management and continued compliance.
Before Ivalua, she served in a variety of roles in increasing seniority, including software companies Infovista and Axway as well as telecommunications company TCL Communication, previously Alcatel Mobile. She started her career in marketing at pharmaceutical giant GSK. She holds a master’s degree from IGS-HR Management School and a master’s degree in International Human Resources from ENS/ENSAM.
Rudolph has served as Chief Financial Officer at Excelya since 2021. He defines group financial strategy and aims to help Excelya scale its business globally. Rudolph joined Excelya after more than 20 years leading finance organizations in the technology sector.
His range of experience includes scaling-up mid-sized startups such as Groupe Allo-Media and Nibelis in a CFO capacity, as well as supporting the expansion and structuring in EMEA of large groups such as Dell Technologies. He has a Master in Finance and Marketing from INSEEC.
Peter serves as Chief Technology Officer at Excelya and is based in Germany. He has over 27 years experience in conducting clinical trials by leveraging the latest technology to obtain reliable results quickly. Before joining Excelya, Peter was VP of Operations and General Partner at PRA Health Sciences.
He began his career in health as a Manager of Information Technology and Data Management before moving up the ranks to Managing Director of various regions in Europe at IMEREM (now part of PRA Health Sciences) and ReSearch Pharmaceutical Services. He has a degree in Mechanical Engineering and Informatics from the Grundig Academy Nuremberg.
Konstantina is the EU Head of Legal Affairs at Excelya, responsible for managing Excelya Group’s legal functions, leading Excelya’s growing in-house legal department. Having forged her legal career working with various international law firms for more than 15 years, Konstantina has joined the CRO industry since 2017 as an in-house counsel of the Zeincro Group of companies and has been a member of the Excelya team since 2020.
Her specialties include deep expertise in the regulatory aspects of clinical trials and late phase studies, corporate law, commercial contracting, M&A, ethics and compliance and corporate governance. She holds a Law Degree from the University of Athens Law School and a Master’s Degree in Commercial Law (LL.M) from the University of Bristol UK Law School.
John joined the Excelya team as our Chief Commercial Officer in 2022 and is based in the Paris office. He has over 20 years of commercial experience, with a main focus in CRO business development. John leads our commercial activities across Excelya’s business solutions and is responsible for ensuring the profitability, growth and the strategic direction of the department, including Business Development, Sales, Proposals and Marketing.
Prior to joining Excelya, John was Head of Global Business Development at Cmed Clinical Research and has previously held business development roles at Chiltern, Theorem Clinical Research and Parexel. This, along with a career encompassing Europe, the Americas and the Asia-Pacific, has given him broad drug development experience in international markets. John has Bachelor Degrees in Commerce and in Science from the University of Auckland, and a Master of Business Administration from ESMT Berlin.
As the Global Head of Clinical Operations at Excelya, Evert Cuppens is responsible for overseeing our clinical operations and project delivery across Europe, ensuring excellence and the highest quality for our clients.
Evert has more than 20 years of experience in drug development, working for both CROs and pharmaceutical companies.
Based in Belgium, he joined Excelya in 2020 through the acquisition of The Clinical Company, where he served as Managing Director BeNeLux/Partner including responsibility for operations and overseeing 80 clinical research professionals in Belgium and The Netherlands.
Evert has a Bachelor of Arts from the University College Leuven-Limburg.